Page last updated: 2024-09-05

tau 284 and Pruritus

tau 284 has been researched along with Pruritus in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	6 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bielory, L; Duttachoudhury, S; McMunn, A	1
Abelson, MB; Gomes, PJ; Gow, JA; McNamara, TR; Torkildsen, GL; Williams, JI	1
Lyseng-Williamson, KA	1
Gow, JA; Klier, SM; McCue, SL; McNamara, TR; Salapatek, AM; Williams, JI	1
Abelson, MB; Gomes, PJ; Gow, JA; Kennedy, KS; McNamara, TR; Torkildsen, GL; Williams, JI	1
Doi, R; Haga, T; Kawakami, T; Kimura, S; Kyoya, M; Nakagawa, K; Soma, Y	1
Fukuoka, M; Ikoma, A; Kabashima, K; Miyachi, Y; Tanizaki, H	1
Andoh, T; Kuraishi, Y	1
Kambe, N; Matsuda, H; Miyachi, Y; Nakamura, Y; Tanaka, A; Tanizaki, H	1

Reviews

3 review(s) available for tau 284 and Pruritus

Article	Year
Bepotastine besilate for the treatment of pruritus. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:18 Topics: Administration, Cutaneous; Administration, Oral; Animals; Clinical Trials as Topic; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Piperidines; Pruritus; Pyridines; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Urticaria	2013
Oral bepotastine: in allergic disorders. Drugs, 2010, Aug-20, Volume: 70, Issue:12 Topics: Administration, Oral; Anti-Allergic Agents; Histamine H1 Antagonists; Humans; Hypersensitivity; Piperidines; Pruritus; Pyridines; Rhinitis, Allergic, Perennial; Urticaria	2010
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. Current medical research and opinion, 2010, Volume: 26, Issue:10 Topics: Animals; Anti-Allergic Agents; Conjunctivitis, Allergic; Disease Models, Animal; Drug Evaluation, Preclinical; Histamine Antagonists; Humans; Mice; Piperidines; Pruritus; Pyridines; Rats	2010

Trials

2 trial(s) available for tau 284 and Pruritus

Article	Year
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen cha Clinical therapeutics, 2009, Volume: 31, Issue:9 Topics: Administration, Topical; Adolescent; Adult; Aged; Allergens; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult	2009
Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperemia; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Time Factors; Young Adult	2011

Article

Year

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen cha

Clinical therapeutics, 2009, Volume: 31, Issue:9

Topics: Administration, Topical; Adolescent; Adult; Aged; Allergens; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult

2009

Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:4

Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperemia; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Prospective Studies; Pruritus; Pyridines; Time Factors; Young Adult

2011

Other Studies

4 other study(ies) available for tau 284 and Pruritus

Article	Year
Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: importance of emotions score in atopic dermatitis. The Journal of dermatology, 2012, Volume: 39, Issue:6 Topics: Adolescent; Adult; Aged; Dermatitis, Atopic; Emotions; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Piperidines; Pruritus; Pyridines; Quality of Life; Surveys and Questionnaires; Young Adult	2012
Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. International archives of allergy and immunology, 2012, Volume: 158, Issue:2 Topics: Adult; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Pruritus; Pyridines; Skin; Terfenadine; Urticaria	2012
Suppression by bepotastine besilate of substance P-induced itch-associated responses through the inhibition of the leukotriene B4 action in mice. European journal of pharmacology, 2006, Oct-10, Volume: 547, Issue:1-3 Topics: Administration, Oral; Animals; Behavior, Animal; Calcium; Dose-Response Relationship, Drug; Ganglia, Spinal; Histamine H1 Antagonists; Leukotriene B4; Male; Mice; Mice, Inbred ICR; Neurons; Neutrophils; Piperidines; Pruritus; Pyridines; Skin; Substance P	2006
Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice. International archives of allergy and immunology, 2008, Volume: 145, Issue:4 Topics: Administration, Oral; Animals; Antipruritics; Behavior, Animal; Dermatitis, Atopic; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; p-Methoxy-N-methylphenethylamine; Piperidines; Pruritus; Pyridines	2008